When compounders introduce a new sterile drug product, they often fail to consider vital aspects such as primary and secondary packaging, leading to complications in drug product sterilization processability, presentation, cost, and time-to-market. To address this challenge, it is crucial to establish a robust and transparent primary and secondary packaging strategy early in the product development process. The following five success factors are essential for this endeavor:
- Begin with primary packaging: Decisions regarding primary packaging significantly impact the requirements for secondary packaging. Therefore, a secondary packaging strategy is best when deciding on primary packaging. For instance, if your product is packaged in a syringe with an autoinjector, the syringe, and its barrel flange must be designed to fit the requirements of the entire injection system. This customization and adaptation are critical for successful secondary packaging development and should be factored into the launch strategy as early as possible. Read More >
